Ironwood Pharmaceuticals Inc. Reg.Shares Class A DL -,001
- BID
3.32
- ASK
3.34
- 18,072 Units17,964 Units
- 07/23, 21:56:27 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
414.29%
Market Cap
1.31 Bil.
P/E Ratio
22.86
Dividend Yield
0.00 %
Earnings per Share
0.13 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 3.32 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 09:56:15 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 3.38 | 3.3 |
| PREV. DAY'S PRICE | 3.42 | (07/22) |
| CHANGE DAY BEFORE | -0.10 | -2.92 % |
| 52 WEEK HIGH / LOW | 4.66 (01/22) | 0.645 (08/05) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -5.96 | 0.01 | 0.13 | 1.04 | 1.08 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | 805.45 | 22.86 | 3.30 | 3.17 |
PRICE - BOOK RATIO | - | - | - | - | - |
PRICE - SALES RATIO | 4.02 | 2.02 | 1.85 | - | - |
PRICE - CASH FLOW RATIO | 9.69 | 6.85 | 4.32 | - | - |
Master Data
| WKN | A0X789 |
| ISIN | US46333X1081 |
| SYMBOL | I76 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | IRONWOOD PHARMA.A DL-,001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 156.53 Mil. |
| MARKET CAPITALISATION | 1.31 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -1.72 % | 3.01 % | -2.84 % | -24.67 % | 414.29 % | -64.19 % | -69.19 % | 28.57 % |
| HIGH | 3.48 | 4.24 | 4.24 | 4.54 | 4.66 | 14.50 | 14.50 | 4.66 |
| LOW | 3.20 | 3.20 | 2.64 | 2.56 | 0.65 | 0.48 | 0.48 | 2.56 |
Dividende
pro Aktie
IRONWOOD PHARMA.A DL-,001 does not deliver dividend information
Company profile
Ironwood Pharmaceuticals, Inc. is a biotechnology company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.